There is no known direct interaction between hormone replacement therapy and GLP-1 medication. The practical question is absorption, because a slower stomach can change how oral hormones are taken up. TelosRX reviews every intake asynchronously through a US-licensed provider, and your full medication list belongs in that review.
Most people can take both, with disclosure. Patches, gels, and other non-oral routes bypass the stomach entirely and are not affected by slowed gastric emptying. Oral hormone therapy passes through the gut, so timing and absorption are worth discussing. Any plan involving both is subject to medical approval by a licensed provider.
Start your intake →What hormone therapy is doing
Hormone replacement therapy replaces hormones the body has stopped producing at previous levels. In menopause that usually means oestrogen, often with a progestogen when the uterus is intact.
It is prescribed for symptoms such as hot flushes, night sweats, disturbed sleep, mood changes, and vaginal dryness, and sometimes for bone health.
The route matters more than people expect. Transdermal patches and gels deliver hormone through the skin into the bloodstream. Oral tablets go through the digestive tract and the liver first.
That difference in route is the whole basis of the absorption question with GLP-1 medication.
Why slowed digestion is the relevant mechanism
GLP-1 medication slows how quickly the stomach empties into the small intestine. That is a core part of how it produces lasting fullness.
Anything swallowed therefore reaches the absorbing surface later than it otherwise would. For most medication that shift is clinically unimportant.
It matters more when a medication has a narrow window between too little and too much, or when the timing of absorption itself matters. Oral hormone therapy is not usually in that category, but it is worth a conversation rather than an assumption.
Compounded medication is not FDA-approved. Adding it alongside existing hormone therapy is subject to medical approval by a licensed provider.
Key takeaway: Route decides the risk. Patches and gels bypass the stomach and are unaffected. Tablets travel through a gut that is now emptying more slowly, which is a timing question for your prescriber.
Contraception is a separate question
Hormone replacement therapy is not contraception. That is one of the most common and most consequential misunderstandings in this area.
If you could become pregnant, you need contraception separately, and you need it before starting GLP-1 medication. This class is not used in pregnancy or while trying to conceive.
Appetite change and weight change can also affect cycles, and some people find ovulation returns when it had been irregular. That is a real possibility rather than a theoretical one.
Raise contraception explicitly during the intake. Do not assume hormone therapy covers it. Start an online visit and state exactly what you take.
Overlapping symptoms are easy to confuse
Menopause and early GLP-1 treatment produce a surprising amount of overlap. Fatigue, nausea, disturbed sleep, mood changes, and digestive upset appear on both lists.
That makes attribution hard. If you start both around the same time, you will not know which one is responsible for what.
Where possible, avoid starting two new things in the same week. Giving each change its own window makes it far easier to tell what is working and what is not.
If you already take hormone therapy and are stable on it, that is usually the simpler sequence. Your provider can factor that in.
Weight change affects hormones on its own
Fat tissue is hormonally active. It produces oestrogen through an enzyme called aromatase, which is why body composition influences circulating hormone levels.
When weight changes substantially, that contribution changes too. Some people notice their hormone therapy feels different as a result, in either direction.
This is not a reason to avoid treatment. It is a reason to keep the prescriber of your hormone therapy informed, so doses can be reviewed if symptoms shift.
TelosRX plans include quarterly labs and unlimited care-team messaging, which makes those conversations easier to have with real information. Begin your evaluation.
Thyroid medication deserves its own note
People sometimes use the phrase hormone replacement loosely to include thyroid hormone. That is a different situation and a more sensitive one.
Levothyroxine absorption is genuinely affected by timing, food, and other medication. A slower stomach is therefore more relevant here than it is for oestrogen.
Do not change your own timing. Tell your prescriber that you are starting a GLP-1, and let them decide whether monitoring or timing needs adjusting.
There is also a separate consideration. A personal or family history of medullary thyroid carcinoma, or multiple endocrine neoplasia type 2, rules out this class of medication entirely.
Gender-affirming hormone therapy
The same principles apply. Non-oral routes are not affected by gastric emptying, oral routes travel through a slower gut, and disclosure is what makes the plan safe.
Weight change can also alter how some hormone effects present, which is worth raising with whoever manages that care.
Say what you take, in what form, and at what frequency during the intake. Providers need the full list rather than the parts you think are relevant.
What TelosRX offers
Compounded semaglutide is available as low as $99 a month. Compounded tirzepatide is available as low as $139 a month. Both are weekly injections.
A needle-free oral GLP-1 is available from $9 a day, dispensing oral semaglutide or oral tirzepatide depending on what your clinician decides. See if the needle-free option fits you.
A microdosed tirzepatide protocol is available as low as $116 a month for people who want a gentler curve. Ask about the microdosed protocol.
The intake takes about five minutes and is reviewed asynchronously by a US-licensed provider, often within hours. Approval is not guaranteed, and you pay nothing if you are declined.
Why midlife weight is genuinely harder
Many people arrive at this question because weight started changing around the menopausal transition, despite nothing else changing.
Several things happen at once. Muscle mass declines with age unless it is actively defended. Fat distribution shifts toward the abdomen. Sleep worsens, and poor sleep raises appetite the following day.
Hormone therapy addresses symptoms. It is not a weight treatment, and expecting it to work as one leads to disappointment.
That is why the two questions often arrive together. One set of tools handles symptoms, another handles weight, and they are managed by their own prescribers.
Protecting muscle and bone at the same time
Bone density falls after menopause, and rapid weight change can add to that concern. This is one of the strongest arguments for a measured pace.
Resistance training is the single most useful habit here. It loads bone, defends muscle, and is more protective than any amount of walking on its own.
Protein at every meal does the other half of the work. Appetite suppression makes that target harder to hit, which is exactly when it matters most.
Calcium and vitamin D status are worth checking rather than guessing. Quarterly labs are included in TelosRX plans, so bring the results to whoever manages your bone health.
What to tell each prescriber
Your hormone prescriber needs to know you are starting a GLP-1, what form it takes, and roughly when you began.
Your GLP-1 prescriber needs the reverse. Every hormone product, its route, its frequency, and anything else you take including supplements.
Neither can make a good decision on half the picture. Most avoidable problems with combined care come from information that was never shared rather than from the medications themselves.
Practical steps if you take both
Write down every hormone product you use, including the route, and bring that list into the intake rather than summarising it.
Keep your hormone therapy on its existing schedule unless the prescriber of that therapy tells you otherwise. A GLP-1 prescriber does not override them.
Watch for a return or worsening of menopausal symptoms in the first months. That is the practical signal that absorption or dose may need reviewing.
Keep fluids and electrolytes steady, since dehydration makes fatigue, headaches, and dizziness worse and those can be mistaken for a hormone problem.
For background on hormone therapy, see the NIH National Library of Medicine overview of hormone replacement therapy. For general menopause information, see the FDA menopause resource.
When to raise it urgently
Some symptoms are not absorption questions and should not be managed by adjusting timing at home.
Seek medical attention for severe or persistent abdominal pain, particularly pain radiating to the back, for repeated vomiting that stops you keeping fluids down, or for signs of dehydration.
Also seek assessment for calf pain or swelling, chest pain, sudden breathlessness, or new severe headaches with visual change. Those are hormone therapy safety concerns in their own right.
Unusual vaginal bleeding after menopause always needs investigation, regardless of what else you are taking. Do not attribute it to a new medication without being checked.
Frequently Asked Questions
Can I take HRT and a GLP-1 at the same time?
Most people can, with disclosure. There is no known direct interaction. The practical issue is absorption of anything swallowed, because a GLP-1 slows gastric emptying. Your provider needs the full list of what you take and in what form.
Does a GLP-1 affect hormone patches or gels?
No. Transdermal routes deliver hormone through the skin straight into the bloodstream, bypassing the stomach entirely. Slowed gastric emptying has no bearing on them, which is why route matters so much here.
Is hormone replacement therapy also contraception?
No, and this is a common and consequential misunderstanding. If you could become pregnant you need contraception separately. GLP-1 medication is not used in pregnancy or while trying to conceive.
Will weight change affect my hormone therapy?
It can. Fat tissue produces oestrogen, so substantial weight change alters that contribution. Some people find their therapy feels different as a result. Keep the prescriber of your hormone therapy informed so doses can be reviewed.
What about thyroid medication?
That is a more sensitive case. Levothyroxine absorption is genuinely affected by timing and food, so a slower stomach is more relevant. Do not change your own timing. Tell your prescriber you are starting a GLP-1.
Should I start both at once?
Where possible, no. Menopause symptoms and early GLP-1 side effects overlap heavily, so starting both together makes it impossible to tell which is causing what. Give each change its own window.
TelosRX is LegitScript-certified. Compounded medication is not FDA-approved and is prepared under federal compounding regulations. This article is general information, not medical advice, and does not replace guidance from your own provider. Approval is subject to evaluation by a licensed provider, and approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.
Already on hormone therapy? Message the TelosRX care team or start your evaluation at TelosRX.